We are live on ! Find out more
Jennison Associates

Jennison Associates Portfolio holdings

AUM $164B Turnover 25.35%
1-Year Est. Return 35.44%
 

Jennison Associates is the research-driven stock investing arm of PGIM, the asset management business of Prudential Financial. It started in 1969, through a predecessor company, managing growth stock accounts of large U.S. companies, mainly for large institutions, and Prudential bought it in 1985. Its growth stock investors believe that rising earnings and cash flow drive share prices, and it also runs long-only and long/short portfolios of global healthcare companies. It began advising mutual funds in 1990 and also manages bond portfolios, choosing investments through its own company-by-company research. Its clients include pension plans, public employee retirement systems, foundations and endowments.

This Fund
S&P 500
This Quarter Est. Return
+4.54%
1 Year Est. Return
+35.44%
3 Year Est. Return
+205.1%
5 Year Est. Return
+278.38%
10 Year Est. Return
+1,734.93%
AUM
$164B
AUM Growth
-$3.15B
Cap. Flow
-$6.03B
Cap. Flow %
-3.69%
Top 10 Hldgs %
44.83%
Holding
647
New
80
Increased
224
Reduced
249
Closed
84
Avg Time Held
3.2 years
Top 10 Avg Time Held
4 years
Top 20 Avg Time Held
4.5 years

Top Buys

Rank Stock Value
1
SNDK icon
Sandisk
SNDK
+$1.15B
2
GLW icon
Corning
GLW
+$880M
3
VRT icon
Vertiv
VRT
+$637M
4
MELI icon
Mercado Libre
MELI
+$617M
5
AMAT icon
Applied Materials
AMAT
+$456M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.66B
2
AAPL icon
Apple
AAPL
+$1.5B
3
AVGO icon
Broadcom
AVGO
+$1.42B
4
TSM icon
TSMC
TSM
+$1.25B
5
ORCL icon
Oracle
ORCL
+$811M

Sector Composition

Rank Sector Weight
1 Technology 46.62%
2 Communication Services 13.3%
3 Consumer Discretionary 10.38%
4 Healthcare 8.83%
5 Industrials 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ETSY icon
301
Etsy
ETSY
$6.6B
$25.1M 0.02%
+351,450
New +$27.8M
2026 Q3
0 quarters
OSCR icon
302
Oscar Health
OSCR
$7.68B
$25.1M 0.02%
+814,472
New +$25M
2026 Q3
0 quarters
AVLN icon
303
Avalyn Pharma
AVLN
$1.26B
$24.7M 0.02%
866,491
+53,742
+7% +$1.73M
2026 Q2
1 quarter
EPD icon
304
Enterprise Products Partners
EPD
$77.3B
$24M 0.01%
673,280
-31,658
-4% -$1.21M
2013 Q4
51 quarters
CELC icon
305
Celcuity
CELC
$2.61B
$23.9M 0.01%
300,358
-58,614
-16% -$5.33M
2025 Q4
3 quarters
MPLX icon
306
MPLX
MPLX
$56.5B
$23.8M 0.01%
421,957
-19,839
-4% -$1.16M
2016 Q2
41 quarters
APMD
307
Apnimed
APMD
$670M
$23.7M 0.01%
+1,083,138
New +$29.1M
2026 Q3
0 quarters
AXON icon
308
Axon Enterprise
AXON
$23.7B
$23.7M 0.01%
56,083
-28,534
-34% -$15.4M
2022 Q4
15 quarters
VALE icon
309
Vale
VALE
$40.4B
$23.5M 0.01%
1,754,781
+330,388
+23% +$4.81M
2024 Q3
8 quarters
FROG icon
310
JFrog
FROG
$12.6B
$23.4M 0.01%
241,169
-235,206
-49% -$21.1M
2025 Q2
5 quarters
SPTX icon
311
Seaport Therapeutics
SPTX
$966M
$23.2M 0.01%
1,151,232
+71,563
+7% +$1.59M
2026 Q2
1 quarter
UCTT icon
312
Ultra Clean Holdings
UCTT
$1.77B
$23.2M 0.01%
+286,456
New +$23.9M
2026 Q3
0 quarters
ENTG icon
313
Entegris
ENTG
$19B
$22.4M 0.01%
145,675
+45,045
+45% +$6.34M
2026 Q1
2 quarters
RKLB icon
314
Rocket Lab
RKLB
$30.6B
$22.2M 0.01%
318,977
+435
+0.1% +$31.3K
2026 Q2
1 quarter
LBRX icon
315
LB Pharmaceuticals
LBRX
$1.26B
$22.1M 0.01%
576,103
+35,201
+7% +$1.45M
2025 Q3
4 quarters
RZLT icon
316
Rezolute
RZLT
$379M
$22.1M 0.01%
5,332,068
+2,872,760
+117% +$13.2M
2026 Q1
2 quarters
DVN icon
317
Devon Energy
DVN
$47.3B
$22M 0.01%
478,775
+174,922
+58% +$8.03M
2026 Q1
2 quarters
FA icon
318
First Advantage
FA
$3.62B
$21.8M 0.01%
1,222,992
+45,934
+4% +$952K
2024 Q3
8 quarters
HAYW icon
319
Hayward Holdings
HAYW
$3.3B
$21.6M 0.01%
1,762,798
-619,235
-26% -$8.96M
2023 Q1
14 quarters
HAL icon
320
Halliburton
HAL
$25.3B
$21.2M 0.01%
667,687
+213,135
+47% +$7.27M
2026 Q2
1 quarter
WRBY icon
321
Warby Parker
WRBY
$2.87B
$20.9M 0.01%
751,507
-711,487
-49% -$18.5M
2023 Q4
11 quarters
GRDN icon
322
Guardian Pharmacy Services
GRDN
$2.97B
$20.9M 0.01%
511,312
-115,352
-18% -$4.7M
2025 Q4
3 quarters
OKE icon
323
Oneok
OKE
$53.2B
$20.8M 0.01%
243,443
-11,386
-4% -$1.05M
2023 Q3
12 quarters
TSEM icon
324
Tower Semiconductor
TSEM
$13.1B
$20.7M 0.01%
91,119
-158,609
-64% -$35.9M
2019 Q3
28 quarters
FAST icon
325
Fastenal
FAST
$58.1B
$20.7M 0.01%
418,365
+221,740
+113% +$10.9M
2026 Q2
1 quarter

Similar funds

Jennison Associates's Q3 2026 Portfolio in Review

As of Q3 2026, Jennison Associates held 647 positions worth $164B, down 1.9% from $167B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Jennison Associates withdrew a net $6.03B in Q3 2026, closing 84 positions and reducing 249 holdings. Its most notable exit was M&T Bank, an estimated $232M position sold in full.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 43% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Jennison Associates opened a new position in Wells Fargo worth $173M.

  • Jennison Associates's largest Q3 2026 buy was Wells Fargo: 2,165,573 shares worth $173M.
  • Jennison Associates added most to Sandisk in Q3 2026, an estimated $1.15B increase.
  • Jennison Associates's biggest Q3 2026 reduction was Amazon, cutting an estimated $1.66B.
  • Jennison Associates fully exited M&T Bank in Q3 2026, selling an estimated $232M.
  • Jennison Associates's ten largest holdings make up 45% of its $164B portfolio in Q3 2026.
  • Jennison Associates opened 80 new positions and closed 84 in Q3 2026.
  • Jennison Associates's portfolio value fell 1.9% quarter-over-quarter to $164B.

Based on Jennison Associates's 13F filing for Q3 2026, filed 16 Nov 2026.